The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma

Journal of Hepatology

Volumn 50, Issue 2, 2009, Pages 358-369

  Chen, Lei ^a   Yan, He Xin ^a   Yang, Wen ^a   Hu, Liang ^a   Yu, Le Xin ^a   Liu, Qiong ^a   Li, Liang ^a   Huang, Dan Dan ^a   Ding, Jin ^a   Shen, Feng ^a   Zhou, Wei Ping ^a   Wu, Meng Chao ^a   Wang, Hong Yang ^a,b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Cholangiocarcinoma; Intrahepatic cholangiocarcinoma; MiRNA expression profiles

Indexed keywords

ANTINEOPLASTIC AGENT; CA 19-9 ANTIGEN; MICRORNA; PROTEIN BCL 2; PROTEIN MCL 1;

ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; ASSAY; CANCER CELL; CONTROLLED STUDY; EMBRYO; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAHEPATIC CHOLANGIOCARCINOMA; LASER CAPTURE MICRODISSECTION; LIVER; LIVER CANCER; MALE; PRIORITY JOURNAL;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CA-19-9 ANTIGEN; CELL LINE, TUMOR; CHOLANGIOCARCINOMA; GENE EXPRESSION PROFILING; HUMANS; MICRODISSECTION; MICRORNAS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 58149277310     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.09.015     Document Type: Article

References (32)

1. Jarnagin W.R., Klimstra D.S., Hezel M., Gonen M., Fong Y., Roggin K., et al. Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome. J Clin Oncol 24 (2006) 1152-1160
2. Isomoto H., Kobayashi S., Werneburg N.W., Bronk S.F., Guicciardi M.E., Frank D.A., et al. Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells. Hepatology 42 (2005) 1329-1338
3. Okaro A.C., Deery A.R., Hutchins R.R., and Davidson B.R. The expression of antiapoptotic proteins Bcl-2, Bcl-X(L), and Mcl-1 in benign, dysplastic, and malignant biliary epithelium. J Clin Pathol 54 (2001) 927-932
4. Endo K., Yoon B.I., Pairojkul C., Demetris A.J., and Sirica A.E. ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions. Hepatology 36 (2002) 439-450
5. Kuroki T., Tajima Y., and Kanematsu T. Hepatolithiasis and intrahepatic cholangiocarcinoma: carcinogenesis based on molecular mechanisms. J Hepatobiliary Pancreat Surg 12 (2005) 463-466
6. Aishima S.I., Taguchi K.I., Sugimachi K., Shimada M., and Tsuneyoshi M. c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma. Histopathology 40 (2002) 269-278
7. Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 113 (2003) 673-676
8. Michael M.Z., O'Connor S.M., van Holst Pellekaan N.G., Young G.P., and James R.J. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1 (2003) 882-891
9. Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65 (2005) 7065-7070
10. Mattie M.D., Benz C.C., Bowers J., Sensinger K., Wong L., Scott G.K., et al. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 5 (2006) 24
11. Yanaihara N., Caplen N., Bowman E., Seike M., Kumamoto K., Yi M., et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9 (2006) 189-198
12. Murakami Y., Yasuda T., Saigo K., Urashima T., Toyoda H., Okanoue T., et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25 (2006) 2537-2545
13. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99 (2002) 15524-15529
14. Lee E.J., Gusev Y., Jiang J., Nuovo G.J., Lerner M.R., Frankel W.L., et al. Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 120 (2007) 1046-1054
15. Roldo C., Missiaglia E., Hagan J.P., Falconi M., Capelli P., Bersani S., et al. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 24 (2006) 4677-4684
16. Chan J.A., Krichevsky A.M., and Kosik K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65 (2005) 6029-6033
17. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., et al. MicroRNA expression profiles classify human cancers. Nature 435 (2005) 834-838
18. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)). Methods 25 (2001) 402-408
19. Chen L., Yan H.X., Chen J., Yang W., Liu Q., Zhai B., et al. Negative regulation of c-Myc transcription by pancreas duodenum homeobox-1. Endocrinology 148 (2007) 2168-2180
20. Gamallo C., Palacios J., Suarez A., Pizarro A., Navarro P., Quintanilla M., et al. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 142 (1993) 987-993
21. Falko F., Michael R.E., Rodrigo C., Kristina C., Jeff L., Lance A.L., et al. Immuno-LCM: laser capture microdissection of immunostained frozen sections for mRNA analysis. Am J Pathol 154 (1999) 61-66
22. Tangkijvanich P., Thong-ngam D., Theamboonlers A., Hanvivatvong O., Kullavanijaya P., and Poovorawan Y. Diagnostic role of serum interleukin 6 and CA 19-9 in patients with cholangiocarcinoma. Hepatogastroenterology 51 (2004) 15-19
23. Huang J.L., Biehl T.R., Lee F.T., Zimmer P.W., and Ryan J.A. Outcomes after resection of cholangiocellular carcinoma. Am J Surg 187 (2004) 612-617
24. Li C., Hong Y., Tan Y.X., Zhou H., Ai J.H., Li S.J., et al. Accurate qualitative and quantitative proteomic analysis of clinical hepatocellular carcinoma using laser capture microdissection coupled with isotope-coded affinity tag and two-dimensional liquid chromatography mass spectrometry. Mol Cell Proteomics 3 (2004) 399-409
25. Liu C.G., Calin G.A., Meloon B., Gamliel N., Sevignani C., Ferracin M., et al. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA 101 (2004) 9740-9744
26. Chen C., Ridzon D.A., Broomer A.J., Zhou Z., Lee D.H., Nguyen J.T., et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33 (2005) e179
27. He H., Jazdzewski K., Li W., Liyanarachchi S., Nagy R., Volinia S., et al. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102 (2005) 19075-19080
28. Chariyalertsak S., Khuhaprema T., Bhudisawasdi V., Sripa B., Wongkham S., and Petmitr S. Novel DNA amplification on chromosomes 2p25.3 and 7q11.23 in cholangiocarcinoma identified by arbitrarily primed polymerase chain reaction. J Cancer Res Clin Oncol 131 (2005) 821-828
29. O'Donnell K.A., Wentzel E.A., Zeller K.I., Dang C.V., and Mendell J.T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435 (2005) 839-843
30. Griffiths-Jones S., Grocock R.J., van Dongen S., Bateman A., and Enright A.J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34 (2006) D140-D144
31. Cimmino A., Calin G.A., Fabbri M., Iorio M.V., Ferracin M., Shimizu M., et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102 (2005) 13944-13949
32. Martin M.M., Lee E.J., Buckenberger J.A., Schmittgen T.D., and Elton T.S. MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J Biol Chem 281 (2006) 18277-18284